RFCA has been associated with a significant elevation in inflammatory mediators (IL-6, TNF-α, CRP) post-procedure, which may contribute to early AF recurrence (ERAF) and potentially impact long-term outcomes (46–49). This evidence concerns the gene TNF and atrial fibrillation.